At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
8-K current report May 19, 2015 5.4 MB View HTML View PDF View XLS  
4 barth, jay May 13, 2015 25.3 KB View HTML View PDF View XLS  
4 valenzano, ken May 12, 2015 27.4 KB View HTML View PDF View XLS  
4 yu, julie May 12, 2015 26.8 KB View HTML View PDF View XLS  
4 quimi, daphne May 12, 2015 26.8 KB View HTML View PDF View XLS  
4 peist, kenneth May 12, 2015 26.7 KB View HTML View PDF View XLS  
4 kirk, john May 12, 2015 26.8 KB View HTML View PDF View XLS  
4 gershkowitz, jayne May 12, 2015 26.8 KB View HTML View PDF View XLS  
4 dilone, enrique May 12, 2015 26.8 KB View HTML View PDF View XLS  
4 castelli, jeff May 12, 2015 26.8 KB View HTML View PDF View XLS  
4 campbell, bradley l May 12, 2015 26.9 KB View HTML View PDF View XLS  
4 baird, william d iii May 12, 2015 26.8 KB View HTML View PDF View XLS  
10-Q quarterly report May 5, 2015 311.1 KB View HTML View PDF View XLS View XBRL  
8-K current report May 5, 2015 73.5 KB View HTML View PDF View XLS  
DEF 14A definitive proxy statement Apr 29, 2015 745.7 KB View HTML View PDF View XLS  
4 do, hung Apr 28, 2015 24.4 KB View HTML View PDF View XLS  
4 david, allsop Apr 28, 2015 22.2 KB View HTML View PDF View XLS  
3 david allsop Apr 28, 2015 20.7 KB View HTML View PDF View XLS  
8-K current report Apr 28, 2015 73.0 KB View HTML View PDF View XLS  
SC 13G statement of beneficial ownership Apr 22, 2015 66.6 KB View HTML View PDF View XLS  
Showing 1-20 of 882 Page: 1 2 3 4 5 ... 45  Next 20

Copyright © 2015 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy